PositiveID Corporation, a life sciences and technology company, develops and sells molecular diagnostic systems for bio-threat detection and medical testing in the United States and internationally. It operates through three segments: Molecular Diagnostics, Medical Devices, and Mobile Labs. The company develops microfluidic systems for the automated preparation and performance of biological assays to detect biological threats and analyze biological samples at the point of need. It has a portfolio of intellectual property related to sample preparation and rapid medical testing applications. The company's microfluidic bio-agent autonomous networked detector (M-BAND) technology is a bio-aerosol monitor with integrated systems for sample collection, processing, and detection modules. Its M-BAND technology analyzes air samples for the detection of pathogenic bacteria, viruses, and toxins for up to 30 days. The company's FireflyDX is an automated pathogen detection system for rapid diagnostics for clinical and point-of-need applications. Its FireflyDX system detects and identifies common pathogens and diseases, such as E. coli, methicillin-resistant staphylococcus aureus, methicillin-susceptible staphylococcus aureus, clostridium difficile, Zika virus, Ebola virus, influenza, and others. In addition, PositiveID Corporation markets Caregiver, a non-contact clinical thermometer that measures forehead temperature in adults, children, and infants for hospitals, physicians' offices, medical clinics, nursing homes and other long-term care institutions, and acute care hospitals; and manufactures and sells specialty technology vehicles for mobile laboratory, command and communications applications, and mobile cellular systems. The company was formerly known as VeriChip Corporation and changed its name to PositiveID Corporation in November 2009. PositiveID Corporation was founded in 2001 and is headquartered in Delray Beach, Florida.
Industry, Sector and Symbol
Stock Exchange OTCMKTS
Industry Analytical instruments
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:PSID
CUSIPN/A
Phone561-805-8008
Debt
Debt-to-Equity RatioN/A
Current Ratio0.01
Quick Ratio0.01
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$5.36 million
Price / Sales0.00
Cash FlowN/A
Price / CashN/A
Book Value($27.01) per share
Price / Book0.00
Profitability
EPS (Most Recent Fiscal Year)N/A
Net Income$-8,560,000.00
Net Margins-166.73%
Return on EquityN/A
Return on Assets-304.11%
Miscellaneous
Employees9
Outstanding Shares9,390,000
Market Cap$10,000.00
PositiveID (OTCMKTS:PSID) Frequently Asked Questions
What is PositiveID's stock symbol?
PositiveID trades on the OTCMKTS under the ticker symbol "PSID."
How were PositiveID's earnings last quarter?
PositiveID Corp (OTCMKTS:PSID) posted its earnings results on Wednesday, November, 19th. The company reported ($0.02) EPS for the quarter, missing the consensus estimate of ($0.01) by $0.01. The firm earned $0.33 million during the quarter, compared to the consensus estimate of $0.40 million. View PositiveID's Earnings History.
Who are some of PositiveID's key competitors?
Some companies that are related to PositiveID include Illumina (ILMN), Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), PerkinElmer (PKI), Bio-Rad Laboratories, Inc. Class B (BIO.B), Bio-Rad Laboratories (BIO), Bruker (BRKR), Coherent (COHR), Horiba (HRIBF), Accelerate Diagnostics (AXDX), Pacific Biosciences of California (PACB), Quanterix (QTRX), Fluidigm (FLDM) and Harvard Bioscience (HBIO).
Who are PositiveID's key executives?
PositiveID's management team includes the folowing people:
- Mr. William J. Caragol, Chairman, CEO & Acting CFO (Age 51)
- Mr. Lyle L. Probst, Pres (Age 47)
- Mr. Gary J. O'Hara, Chief Technology Officer (Age 68)
- Ms. Allison F. Tomek, Sr. VP of Corp. Devel. & Sec.
- Dr. Kimothy Smith, Chief Technology Advisor & Member of Advisory Board
Has PositiveID been receiving favorable news coverage?
Media headlines about PSID stock have trended somewhat positive recently, Accern Sentiment reports. Accern identifies negative and positive news coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. PositiveID earned a daily sentiment score of 0.18 on Accern's scale. They also gave media coverage about the company an impact score of 46.57 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near future. View Recent Headlines for PositiveID.
How do I buy shares of PositiveID?
Shares of PSID can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is PositiveID's stock price today?
One share of PSID stock can currently be purchased for approximately $0.0005.
How big of a company is PositiveID?
PositiveID has a market capitalization of $10,000.00 and generates $5.36 million in revenue each year. PositiveID employs 9 workers across the globe.
How can I contact PositiveID?
PositiveID's mailing address is 1690 SOUTH CONGRESS AVENUE SUITE 201, DELRAY BEACH FL, 33445. The company can be reached via phone at 561-805-8008.
MarketBeat Community Rating for PositiveID (OTCMKTS PSID)
MarketBeat's community ratings are surveys of what our community members think about PositiveID and other stocks. Vote "Outperform" if you believe PSID will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PSID will underperform the S&P 500 over the long term. You may vote once every thirty days.
